课题基金 / 基金详情

12th International Conference on the Molecular Biology and Pathogenesis of Clostridia (Clostpath 12)

12th International Conference on the Molecular Biology and Pathogenesis of Clostridia (Clostpath 12)
第十二届梭状芽胞杆菌分子生物学和发病机制国际会议 (Clostridia 12)
批准号:
10318438
负责人:
Dana Borden Lacy
金额:
$1.1万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-07-12 至 2022-06-30

项目摘要

项目成果

Dana Borden Lacy的其他基金

相似基金

相关文献

中文摘要
翻译
总结 梭菌分子生物学和发病机制国际会议(Clostpath)已于 领先的场地,汇集科学家,临床医生,病理学家在研究的前沿, 梭菌的分子生物学及其在健康和疾病中的作用。为了保持这一传统,Clostpath 12将 涵盖梭菌依赖性发病机制的所有基本和转化方面。议题将包括 毒力基因调控,毒力因子结构和机制,宿主-病原体-微生物组相互作用, 孢子动力学和传播,研究梭菌生物的新技术的发展,以及 作为用于检测、诊断、治疗和预防梭菌引起的疾病的创新。 会议将于2021年9月13日至16日在阿尔伯塔的班夫举行,班夫位于阿尔伯塔省的中心地带。 加拿大落基山脉。 Clostpath 12的节目是故意在其重点放在多样性和包容性,以及提供 为年轻科学家提供机会。在Clostpath会议上,传统上有9个会议,邀请12-20人 发言人-全体会议(无平行会议)。将从以下项目中选出大约25个额外的口头报告: 提交摘要。组委会、国际指导委员会和受邀者名单 演讲者反映了Clostpath社区的地理,科学和种族/性别/种族多样性。 将有~150海报提出,分为两个海报会议。在全体会议上, 也将为选定的海报摘要进行快闪演讲。为了促进网络互动, 包括会议第一天的欢迎招待会/工作晚餐,会议晚餐/派对 在最后一个晚上,和可选的短途旅行。此外,一个青年科学家委员会正在培养实习生- 具体内容和活动纳入方案。 第12届会议的目标将是:(一)继续提出最高质量的最新研究, 致病性梭菌在一个论坛,促进信息交流和未来的合作和(ii)培训 并激励年轻的梭菌研究人员,他们将成为该领域的下一代领导者。这些目标 将通过两个具体目标来实现:目标1:邀请、支持和鼓励年轻人的参与 调查人员和代表性不足的科学家。目标2:提供一个环境,鼓励大学生交流 科学思想和分享该领域的最新发现。
英文摘要
SUMMARY The International Conference on the Molecular Biology and Pathogenesis of the Clostridia (Clostpath) has been the leading venue to bring together scientists, clinicians, and pathologists at the forefront of research on the molecular biology of clostridia and their role in health and disease. In keeping with this tradition, Clostpath12 will cover all fundamental and translational aspects of clostridial-dependent pathogenesis. Topics will include virulence gene regulation, virulence factor structure and mechanism, host-pathogen-microbiome interactions, spore dynamics and transmission, the development of new technologies to study clostridial organisms, as well as innovations designed for the detection, diagnosis, treatment and prevention of clostridial-caused diseases. The meeting will take place September 13-16, 2021 in Banff, Alberta, which is located in the heart of the Canadian Rockies. The programming for Clostpath12 is deliberate in its focus on diversity and inclusion as well as providing opportunities to young scientists. At Clostpath conferences, there are traditionally 9 sessions, with 12-20 invited speakers – all plenary (no parallel sessions). Approximately 25 additional oral presentations will be selected from submitted abstracts. The Organizing Committee, the International Steering Committee, and the list of invited speakers reflect the full geographic, scientific, and ethnic/gender/racial diversity of the Clostpath community. There will be ~150 posters presented, divided over two poster sessions. During the plenary presentations, there will also be flash talks for selected poster abstracts. To foster networking interactions, there is a social program that includes a welcome reception/working dinner on the first day of the conference, a conference dinner/party on the final evening, and optional excursions. In addition, a young scientist committee is developing trainee- specific content and activities to be integrated into the program. The objectives for the 12th Conference will be (i) to continue presenting the highest-quality, recent research on pathogenic clostridia in a forum that facilitates information exchange and future collaborations and (ii) to train and inspire young clostridial researchers who will be the next generation of leaders in the field. These objectives will be realized through two specific aims: Aim 1: Invite, support, and encourage the participation of young investigators and underrepresented scientists. Aim 2: Provide a setting that encourages collegial exchange of scientific ideas and sharing of the most current discoveries in the field.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Vanderbilt Antibody and Antigen Discovery for Clostridioides difficile Vaccines
Project 1: Mucosal toxin subunit immunization as a strategy for C. difficile vaccine development
Administrative Core
The role of toxins in Clostridium difficile infection pathogenesis
  • 批准号:
    10412917
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    2015
  • 负责人:
    Dana Borden Lacy
  • 依托单位:
海外基金